Birdwatch Note
2021-09-03 01:23:07 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
The tweet suggests that the widespread use of ivermectin is being misrepresented in the media because ivermectin is also used in humans. But what is being reported is that people are consuming veterinary ivermectin formulated for horses in high doses—which is accurate. https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19
Written by 24800F38745385B32D56606DAF02CF99
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1433438082213220358
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1433601418854690835
- noteId - 1433601418854690835
- participantId - 24800F38745385B32D56606DAF02CF99
- noteAuthorParticipantId -
- createdAtMillis - 1630632187938
- tweetId - 1433438082213220358
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable - BELIEVABLE_BY_MANY
- harmful - CONSIDERABLE_HARM
- validationDifficulty - EASY
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- The tweet suggests that the widespread use of ivermectin is being misrepresented in the media because ivermectin is also used in humans. But what is being reported is that people are consuming veterinary ivermectin formulated for horses in high doses—which is accurate. https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2021-09-03 01:23:07 UTC (1630632187938) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
24800F38745385B32D56606DAF02CF99 | ||
2021-09-03 01:23:07 UTC (1630632187938) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
A4884A579E949BF2CC831780FA8E7CDD13AA2989AC97DE8F1B0A85CD050E258D |
Note Ratings
rated at | rated by | |
2021-09-05 16:38:14 -0500 | 0378F20DFECC73D3AD98390D25AA66E2BCCAAB4A22DEE65AB440D4CB6446B2E7 | Rating Details |
2021-09-02 22:34:56 -0500 | 06D9272BFC9FA1A6AF5ABF549D0293F4 | Rating Details |
2021-09-06 10:10:47 -0500 | 0834718FE64CDC2DEE5B0567C821087CE968FBE09352EF3C9FD03480381E21A1 | Rating Details |
2021-09-03 04:09:08 -0500 | 086D4A0E9BB42E0425E20163ED277D19579C73956EEEE4AF6E3723875E6E48E0 | Rating Details |
2021-09-03 05:58:32 -0500 | 08C1C249AEED26E5A6BEA8A4BE333C03 | Rating Details |
2021-09-04 23:49:53 -0500 | 0F2C0694AE7E1C4332B49E908748C080 | Rating Details |
2021-09-06 00:44:01 -0500 | 104EA57F6C7B57F52F360CD24FC28053B11730E7B562C639D3B0F4BE774A5CF4 | Rating Details |
2021-09-02 20:57:01 -0500 | 10A0C8DF815EFDC906A31F576198F0A2 | Rating Details |
2021-09-03 01:52:03 -0500 | 18F650149F79419AE5835C8CFCBF6034 | Rating Details |
2021-09-04 22:14:37 -0500 | 1ABA0EF359457AE2C80774DD333144EE320CD8F95B3D40A107246EC57A919A99 | Rating Details |
2021-09-03 05:56:45 -0500 | 1B5DD4E535405F1075972ECB0C3D3B41 | Rating Details |
2021-09-02 23:26:11 -0500 | 1C85F79694D834FB8579F008B0872BCE0299A9023C8D9FE5C9086CACBA929146 | Rating Details |
2021-09-03 00:46:45 -0500 | 1E450DE2E853304CFA9C2789AC1F15996403BB7970C34EB01F1399AAE9C722E9 | Rating Details |
2021-09-04 20:56:05 -0500 | 1FE436EF14327DBEF977B87FC67B23A585B11037E9FF450F9E165F6A825A0D79 | Rating Details |
2021-09-05 22:39:41 -0500 | 200D6EC440D40603B5D481A1DB038253 | Rating Details |
2021-09-03 02:12:36 -0500 | 21E88E60D1A3437F917CADF7AF2FEC38DC7608F7C01589A38760498FB27932A2 | Rating Details |
2021-09-08 06:35:35 -0500 | 227B72516F48209D4CD398BD566B39A53B64980200BCA4A4C749072F49AA8384 | Rating Details |
2021-09-04 20:18:26 -0500 | 27A7115A6B440805D8096AD76D43E991 | Rating Details |
2021-09-04 20:18:26 -0500 | 28D70A0C50701ED9DD97E93B389344B3F6F0AD6F2C533A08D96A40B2681F71F6 | Rating Details |
2021-09-04 20:02:41 -0500 | 2AD40299055AEB071D5BC5A91F2B8C04 | Rating Details |
2021-09-03 05:56:45 -0500 | 2DE0FEC07E33D5F2B6E315DA8EF5A82B60CFC6B87E29A8047161EC7E4A45269A | Rating Details |
2021-09-04 17:45:48 -0500 | 31EE6071E170C0FBE04C6A1D9BF99AEDA64A9BBA78CC37BE26D26A134B6906D6 | Rating Details |
2021-09-03 05:58:32 -0500 | 33FFD11B743A4C3E9185BA3D58E1CA8618131A381148F5AAF98D8961609426EE | Rating Details |
2021-09-02 21:21:11 -0500 | 35641D9F182232EF30D178C48FA348620D1FFC8EC3BAC47C96F5CA8D15993022 | Rating Details |
2021-09-03 04:48:41 -0500 | 39D545EED96449F2040AF389F67BF69DDD79BFAB23A90B9F1BA9F5D917424C41 | Rating Details |
2021-09-04 15:48:15 -0500 | 3ACA22B4CAA1B8E9CB14CEB6843CB2CE171169635F08A6DEE7D896EA346A6CB2 | Rating Details |
2021-09-04 20:02:41 -0500 | 3B1386388FFCEC3000878BC34276B41EE39532217B57E3D01BD366D3CB6AE128 | Rating Details |
2021-09-03 07:20:42 -0500 | 3B501A9ED3799DDC4F249C02F6C5178594D6B520E01025C690FDB9A155166D9A | Rating Details |
2021-09-03 17:03:59 -0500 | 3D8937C8D4CA66F90A71B6441E253133F637D96FB749C3ACDFEF6E8B1BBA8E14 | Rating Details |
2021-09-04 20:14:26 -0500 | 45658B1027B52F87FCED0B8826A4011259A66951563DDA4928B231981531ADD5 | Rating Details |
2021-09-06 10:10:47 -0500 | 4A13B4BC52863208CEA403E5F64119D1 | Rating Details |
2021-09-04 17:45:48 -0500 | 4A33231C6021A2873ECD62A5EB9D89E1 | Rating Details |
2021-09-04 22:14:37 -0500 | 4B7DA55613F6CD0481B4D7620F3E6F13 | Rating Details |
2021-09-04 23:49:53 -0500 | 4C24F3E664F4D5BB89129B79F3CE275E2E72123B36EC71E4A6BBDEF9644E2E09 | Rating Details |
2021-09-04 12:33:54 -0500 | 4F9E13BBF861C14D34BD7CABE9D712A2 | Rating Details |
2021-09-02 21:52:57 -0500 | 562C979B44CA675FF61991D62F444DF2 | Rating Details |
2021-09-03 03:10:24 -0500 | 59844C1E37A2793226339D9ECAE0175D52D5D3AD5B0B4C24DCCF1D2210ED82F3 | Rating Details |
2021-09-02 22:34:56 -0500 | 5BB91550D335CB1CEBD6FBCE92A26255C817EA03415D9638C76908E6C04B1B73 | Rating Details |
2021-09-02 23:50:34 -0500 | 689C77F5B407A5645516B0DCBA607B4C191926ECD4A2E4C5E36B18C8B684A988 | Rating Details |
2021-09-02 21:52:57 -0500 | 6CA275727E456EF98CBEDEC11FBDEDCF3B63EF9B9C7261F7CCFC0C58C5D2DF63 | Rating Details |
2021-09-03 02:12:36 -0500 | 6EB6C59E5F9434FA21AB0643E1F2DA57 | Rating Details |
2021-09-03 00:46:45 -0500 | 6FDE86CE4C3E51E2203DBFCBF3EC28C7 | Rating Details |
2021-09-04 20:54:46 -0500 | 74EB7B02FA677556EAFC5F54BCF74CA6 | Rating Details |
2021-09-04 12:33:54 -0500 | 752BE5AE7222B47517A7BE6833A2BB396A821B47F2C48C4D6DACB64A56646F1A | Rating Details |
2021-09-04 20:14:26 -0500 | 8018730C1D2B65C049DE122D1B7227BD | Rating Details |
2021-09-05 20:55:50 -0500 | 84549C8BD80F7DC859F6D61F7E176324 | Rating Details |
2021-09-03 17:03:59 -0500 | 86D87C6A32C0F45008E1704F32AD4BE3 | Rating Details |
2021-09-03 07:20:42 -0500 | 94768A7F58CCF3768C7BFEFDC6F28B8D | Rating Details |
2021-09-04 20:01:32 -0500 | 952A174D91B5D6ED3B6A7AE915FFB235 | Rating Details |
2021-09-04 14:26:30 -0500 | 9CFA1D90A0388EBA92575E9388BEF00CF76F31DBBD3343522205AFE1DC4E8F74 | Rating Details |
2021-09-02 20:57:01 -0500 | A2740A6BE91635873321C12E94658229F96A7214CE75E5F01C31E5AE6D0EEB64 | Rating Details |
2021-09-04 20:01:32 -0500 | A5A05EBC456072B1A6CDD90BE100060F0A177C23E42F33421214F9F9D35975CB | Rating Details |
2021-09-06 21:45:10 -0500 | A8574890E46728D7BFCEAC195F9CCC3E7096BA465929092DC6E668163AC76FB5 | Rating Details |
2021-09-05 16:38:14 -0500 | A8CB5D5E5A53FEA286C15D44FBE39BF6 | Rating Details |
2021-09-02 23:50:34 -0500 | AE32A09260E6B7BD21ECB6166F14ADD0 | Rating Details |
2021-09-03 02:38:45 -0500 | AEBA5DB4C7468B58F6A8CCF7E4CDE241698C88BBF4C0D78466A2C3666AF3F225 | Rating Details |
2021-09-03 03:10:24 -0500 | AFEDD329632686EB0210653E3032EE3F | Rating Details |
2021-09-03 04:09:08 -0500 | B0BEBB215EC6ED1A5930D0F7F8083F84 | Rating Details |
2021-09-03 01:52:03 -0500 | B41247447CF0EC824B15AEE3CC37FE478E1F6822AFA1C4AF60487E7916916176 | Rating Details |
2021-09-08 06:35:35 -0500 | B47391ADD314142E98ADB1447C70FB98 | Rating Details |
2021-09-04 20:56:05 -0500 | BB9987472F8C194F49FA04D40BF8B787 | Rating Details |
2021-09-06 00:44:01 -0500 | BF6EA1DC6A8E6B8A87AEB14D7DAFC208 | Rating Details |
2021-09-02 21:13:08 -0500 | C255AC9F66C75A29CE6471192A4EF58F | Rating Details |
2021-09-05 20:55:50 -0500 | C3FFD7C9E9A80EF495CC6D610A1F946A75F4B52870674A852E00DA383B64D368 | Rating Details |
2021-09-03 02:38:45 -0500 | CCC34D3AC7378DEC046BC60D65DE17DB | Rating Details |
2021-09-03 04:48:41 -0500 | D584EDA4E40D8B90330C7525F39D81E0 | Rating Details |
2021-09-04 20:54:46 -0500 | E42B1D721B145900EBDBABB77E5F8AEED34BCD48C669BC7959D811AB98C104ED | Rating Details |
2021-09-06 21:45:10 -0500 | E644A59D768FB077D77EB155714A915B | Rating Details |
2021-09-04 14:26:30 -0500 | E72290E425D4E5B3A960B98A5970D2DC | Rating Details |
2021-09-02 21:13:08 -0500 | EA4D5345704D558FF255296BAA00D6A99D33CE65A374ADA8B1E1CBA8350A94BD | Rating Details |
2021-09-02 21:21:11 -0500 | ED6B36839B35EC2B7CABAFDA41967173 | Rating Details |
2021-09-05 22:39:41 -0500 | EDC2A85BEFA540CF22ED66F22F1561877B5E0ADF6C02F2AA0CFEE7ADEE6564AC | Rating Details |
2021-09-02 23:26:11 -0500 | F0096A276CAD363C1C10208B9535C415 | Rating Details |
2021-09-04 15:48:15 -0500 | F9019264E8865453A1EF8F4496689A8D | Rating Details |
2021-09-04 15:48:15 -0500 | Rating Details | |
2021-09-04 14:26:30 -0500 | Rating Details | |
2021-09-04 22:14:37 -0500 | Rating Details | |
2021-09-03 05:58:32 -0500 | Rating Details | |
2021-09-03 01:52:03 -0500 | Rating Details | |
2021-09-04 20:02:41 -0500 | Rating Details | |
2021-09-04 20:01:32 -0500 | Rating Details | |
2021-09-02 21:21:11 -0500 | Rating Details | |
2021-09-04 20:14:26 -0500 | Rating Details | |
2021-09-02 21:52:57 -0500 | Rating Details | |
2021-09-03 05:56:45 -0500 | Rating Details | |
2021-09-02 23:26:11 -0500 | Rating Details | |
2021-09-03 04:09:08 -0500 | Rating Details | |
2021-09-03 02:12:36 -0500 | Rating Details | |
2021-09-04 17:45:48 -0500 | Rating Details | |
2021-09-02 21:13:08 -0500 | Rating Details | |
2021-09-02 22:34:56 -0500 | Rating Details | |
2021-09-02 20:57:01 -0500 | Rating Details | |
2021-09-02 23:50:34 -0500 | Rating Details | |
2021-09-03 00:46:45 -0500 | Rating Details | |
2021-09-04 23:49:53 -0500 | Rating Details | |
2021-09-06 00:44:01 -0500 | Rating Details | |
2021-09-04 20:18:26 -0500 | Rating Details | |
2021-09-04 20:56:05 -0500 | Rating Details | |
2021-09-06 21:45:10 -0500 | Rating Details | |
2021-09-03 17:03:59 -0500 | Rating Details | |
2021-09-03 07:20:42 -0500 | Rating Details | |
2021-09-03 04:48:41 -0500 | Rating Details | |
2021-09-06 10:10:47 -0500 | Rating Details | |
2021-09-04 20:54:46 -0500 | Rating Details | |
2021-09-03 03:10:24 -0500 | Rating Details | |
2021-09-05 16:38:14 -0500 | Rating Details | |
2021-09-03 02:38:45 -0500 | Rating Details | |
2021-09-04 12:33:54 -0500 | Rating Details | |
2021-09-05 22:39:41 -0500 | Rating Details | |
2021-09-05 20:55:50 -0500 | Rating Details | |
2021-09-08 06:35:35 -0500 | Rating Details |